We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $10.1B
1-Year Est. Return 42.88%
This Fund
S&P 500
This Quarter Est. Return
-27.19%
1 Year Est. Return
+42.88%
3 Year Est. Return
+92.52%
5 Year Est. Return
+113.84%
10 Year Est. Return
+608.05%
AUM
$7.34B
AUM Growth
-$3.86B
Cap. Flow
-$375M
Cap. Flow %
-5.12%
Top 10 Hldgs %
9.89%
Holding
1,223
New
86
Increased
388
Reduced
436
Closed
75

Top Buys

Rank Stock Value
1
ESE icon
ESCO Technologies
ESE
+$40.8M
2
HAE icon
Haemonetics
HAE
+$37.6M
3
ROG icon
Rogers Corp
ROG
+$26.2M
4
EVR icon
Evercore
EVR
+$25.5M
5
FARO
Faro Technologies
FARO
+$22M

Top Sells

Rank Stock Value
1
AVX
AVX Corporation
AVX
+$71.1M
2
VIRT icon
Virtu Financial
VIRT
+$51M
3
ALGT icon
Allegiant Air
ALGT
+$26.6M
4
KEX icon
Kirby Corp
KEX
+$26.3M
5
FELE icon
Franklin Electric
FELE
+$26.2M

Sector Composition

Rank Sector Weight
1 Industrials 25.72%
2 Technology 19.64%
3 Financials 14.17%
4 Consumer Discretionary 10.37%
5 Healthcare 9.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SXI icon
751
Standex International
SXI
$3.59B
$900K 0.01%
18,355
-1,169
-6% -$76.8K
STT icon
752
State Street
STT
$50.6B
$895K 0.01%
16,800
– –
INVA icon
753
Innoviva
INVA
$1.55B
$890K 0.01%
75,682
-267
-0.4% -$3.53K
INMD icon
754
InMode
INMD
$870M
$882K 0.01%
+82,000
New +$1.45M
BLUE
755
DELISTED
bluebird bio
BLUE
$873K 0.01%
1,467
– –
SSTK icon
756
Shutterstock
SSTK
$198M
$873K 0.01%
27,146
-255
-0.9% -$10.2K
MGLN
757
DELISTED
Magellan Health Services, Inc.
MGLN
$867K 0.01%
18,015
+4,515
+33% +$290K
ENV
758
DELISTED
ENVESTNET, INC.
ENV
$860K 0.01%
16,000
-12,000
-43% -$860K
HRTX icon
759
Heron Therapeutics
HRTX
$93.9M
$852K 0.01%
72,600
– –
IOTS
760
DELISTED
Adesto Technologies Corp
IOTS
$846K 0.01%
75,600
-1,015,599
-93% -$9.7M
EZPW icon
761
Ezcorp Inc
EZPW
$1.83B
$838K 0.01%
201,000
– –
MTUS icon
762
Metallus
MTUS
$838M
$837K 0.01%
259,105
-39,916
-13% -$223K
SEDG icon
763
SolarEdge
SEDG
$2.51B
$830K 0.01%
10,139
-5,305
-34% -$561K
WEX icon
764
WEX
WEX
$6.37B
$826K 0.01%
7,900
+7,300
+1,217% +$1.36M
PRAH
765
DELISTED
PRA Health Sciences, Inc.
PRAH
$826K 0.01%
9,949
– –
NGVC icon
766
Vitamin Cottage Natural Grocers
NGVC
$739M
$820K 0.01%
+96,371
New +$829K
JEF icon
767
Jefferies Financial Group
JEF
$12.6B
$816K 0.01%
62,446
– –
PRO
768
DELISTED
PROS Holdings
PRO
$807K 0.01%
26,000
+4,000
+18% +$200K
RMBS icon
769
Rambus
RMBS
$9.87B
$795K 0.01%
71,660
-6,254
-8% -$86.6K
CENT icon
770
Central Garden & Pet Co
CENT
$2.69B
$790K 0.01%
35,916
+9,831
+38% +$232K
SHSP
771
DELISTED
SharpSpring, Inc.
SHSP
$788K 0.01%
130,000
– –
CORT icon
772
Corcept Therapeutics
CORT
$12.4B
$778K 0.01%
65,441
-1,271
-2% -$15.7K
GKOS icon
773
Glaukos
GKOS
$9.83B
$775K 0.01%
25,125
– –
HI
774
DELISTED
Hillenbrand
HI
$772K 0.01%
40,375
+958
+2% +$24.9K
PRLB icon
775
Protolabs
PRLB
$1.79B
$761K 0.01%
10,000
-31,438
-76% -$2.91M
29 30
31
32 33

Similar funds

GI
GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return
IIM
INTECH Investment Management West Palm Beach, Florida $10.2B AUM 28.14% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VPIM
Vanguard Personalized Indexing Management Oakland, California $10.2B AUM 34.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
OIA
OneDigital Investment Advisors Overland Park, Kansas $10.2B AUM 16.58% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
FPAS
Focus Partners Advisor Solutions Saint Louis, Missouri $9.92B AUM 21.52% 1-Year Est. Return

Royce & Associates's Q1 2020 Portfolio in Review

As of Q1 2020, Royce & Associates held 1,223 positions worth $7.34B, down 34% from $11.2B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.

Royce & Associates withdrew a net $375M in Q1 2020, closing 75 positions and reducing 436 holdings. Its most notable exit was AVX Corporation, an estimated $71.1M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 26% of assets, down from 27% a quarter earlier, followed by Technology and Financials.

Against the trend, Royce & Associates opened a new position in ESCO Technologies worth $33.9M.

  • Royce & Associates's largest Q1 2020 buy was ESCO Technologies: 447,118 shares worth $33.9M.
  • Royce & Associates added most to Haemonetics in Q1 2020, an estimated $37.6M increase.
  • Royce & Associates's biggest Q1 2020 reduction was Virtu Financial, cutting an estimated $51M.
  • Royce & Associates fully exited AVX Corporation in Q1 2020, selling an estimated $71.1M.
  • Royce & Associates's ten largest holdings make up 9.9% of its $7.34B portfolio in Q1 2020.
  • Royce & Associates opened 86 new positions and closed 75 in Q1 2020.
  • Royce & Associates's portfolio value fell 34% quarter-over-quarter to $7.34B.

Based on Royce & Associates's 13F filing for Q1 2020, filed 12 May 2020.